Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Behind the Scenes of Drug Registration Unraveling Regulatory Challenges
*Corresponding Author:Received Date: Feb 01, 2024 / Published Date: Feb 29, 2024
Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
The journey from drug development to market approval is a labyrinthine process, with drug registration standing as a pivotal point. This article provides an in-depth exploration of the complexities faced behind the scenes of drug registration, unraveling the regulatory challenges encountered by pharmaceutical companies. From stringent documentation requirements to navigating international regulations and addressing evolving standards, the article delves into the intricacies of this critical phase in the drug development lifecycle. Strategies for overcoming these challenges are also discussed, emphasizing the importance of early engagement with regulatory authorities, technological integration, cross-functional collaboration, and continuous education. Understanding and addressing these regulatory challenges are imperative for ensuring the successful and compliant registration of new drugs
